- 移动端
武汉原生原代生物医药科技有限公司品牌商
5 年
手机商铺
商家活跃：
产品热度：
- NaN
- 0.5
- 0.5
- 2.5
- 2.5
公司新闻/正文
贺上海交通大学医学院应用PriCells产品/技术服务发表文章
325 人阅读发布时间：2015-04-02 17:04
贺上海交通大学医学院应用PriCells产品/技术服务发表文章
HIC1 modulates prostate cancer progression by epigentic modification
Clinical Cancer Research, January 22, 2013; doi: 10.1158/1078-0432.
Jianghua Zheng1, Jinglong Wang1, Xueqing Sun1, Mingang Hao1, Tao Ding2, Dan Xiong1, Xiumin Wang1, Yu Zhu3, Gang Xiao1, Guangcun Cheng1, Meizhong Zhao4, Jian Zhang5, and Jianhua Wang1,*
1Biochemistry and Molecular cell biology, Shanghai Jiao-Tong University School of Medicine
2Urology, Shanghai Putuo Hospital, Shanghai Traditional Chinese Medicine University
3Urology, Shanghai Ruijin Hospital
4Comprehensive Breast Health Cente, Shanghai Ruijin Hospital
5Translational Biology, Guangxi Medical University
HUM-CELL-0057, PriCells, Wuhan, China
HIC1 modulates prostate cancer progression by epigentic modification
Clinical Cancer Research, January 22, 2013; doi: 10.1158/1078-0432.
Jianghua Zheng1, Jinglong Wang1, Xueqing Sun1, Mingang Hao1, Tao Ding2, Dan Xiong1, Xiumin Wang1, Yu Zhu3, Gang Xiao1, Guangcun Cheng1, Meizhong Zhao4, Jian Zhang5, and Jianhua Wang1,*
1Biochemistry and Molecular cell biology, Shanghai Jiao-Tong University School of Medicine
2Urology, Shanghai Putuo Hospital, Shanghai Traditional Chinese Medicine University
3Urology, Shanghai Ruijin Hospital
4Comprehensive Breast Health Cente, Shanghai Ruijin Hospital
5Translational Biology, Guangxi Medical University
HUM-CELL-0057, PriCells, Wuhan, China